Velmanase alfa, sold under the brand name Lamzede, is a medication for the treatment of alpha-mannosidosis. Velmanase alfa is a recombinant form of human alpha-mannosidase. Velmanase alfa was approved for medical use in the European Union in March 2018.
Attributes | Values |
---|---|
rdf:type | |
rdfs:label |
|
rdfs:comment |
|
dct:subject | |
Wikipage page ID |
|
Wikipage revision ID |
|
Link from a Wikipage to another Wikipage | |
Link from a Wikipage to an external page | |
sameAs | |
dbp:wikiPageUsesTemplate | |
ATC suffix |
|
ATC prefix |
|
CAS number |
|
DrugBank |
|
KEGG |
|
routes of administration | |
tradename |
|
UNII |
|
has abstract |
|
legal EU |
|
licence EU |
|
prov:wasDerivedFrom | |
page length (characters) of wiki page |
|
alternative name |
|
CAS number |
|
DrugBank |
|
FDA UNII code |
|
KEGG |
|
foaf:isPrimaryTopicOf | |
is Link from a Wikipage to another Wikipage of | |
is Wikipage redirect of | |
is foaf:primaryTopic of |